Atosiban does not improve neonatal outcomes in threatened preterm births between 30-34 weeks
1. Perinatal mortality and neonatal morbidity were comparable between the atosiban and placebo groups. 2. Maternal adverse events were similar ...
1. Perinatal mortality and neonatal morbidity were comparable between the atosiban and placebo groups. 2. Maternal adverse events were similar ...
1. Pregnancy loss was reported among 8.0% of patients in the monofilament suture group and 7.6% of patients in the ...
1. Half-dose antenatal betamethasone did not meet the noninferiority criteria when compared to full dose at preventing the primary outcome ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.